株式会社D&Mカンパニー Logo

株式会社D&Mカンパニー

Optimizing healthcare & welfare businesses via finance, consulting, and HR solutions.

189A | T

Overview

Corporate Details

ISIN(s):
JP3548490006
LEI:
Country:
Japan
Address:
大阪市北区梅田二丁目5番25号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

D&M COMPANY CO.,LTD is a specialized provider of comprehensive business support services for the medical, nursing care, and welfare industries. The company offers integrated, one-stop solutions structured around three core pillars: Finance & Investment (F&I), Consulting & Business Renovation (C&Br), and Human Resources & Outsourcing (HR&OS). The F&I division provides financial solutions such as medical fee receivables factoring and leasing. The C&Br division offers management consulting, including organizational reform, profit improvement support, and M&A advisory. The HR&OS division delivers staffing services like personnel placement, temporary staffing, and outsourcing. By holistically addressing key client challenges in finance, management, and human resources, D&M aims to achieve overall business optimization for healthcare and welfare service providers.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-12 07:31
Registration Form
有価証券届出書(組込方式)
Japanese 330.4 KB
2025-08-25 06:04
Registration Form
有価証券報告書-第10期(2024/06/01-2025/05/31)
Japanese 1.3 MB
2025-08-25 06:04
Registration Form
確認書
Japanese 9.2 KB
2025-01-14 05:43
Report Publication Announcement
確認書
Japanese 9.3 KB
2025-01-14 05:41
Interim Report
半期報告書-第10期(2024/06/01-2025/05/31)
Japanese 179.0 KB
2024-08-27 03:02
Post-Annual General Meeting Information
臨時報告書
Japanese 23.8 KB
2024-08-26 08:01
Registration Form
確認書
Japanese 8.8 KB
2024-08-26 08:00
Annual Report
有価証券報告書-第9期(2023/06/01-2024/05/31)
Japanese 1.3 MB
2024-06-03 08:00
Registration Form
訂正有価証券届出書(新規公開時)
Japanese 1.6 MB
2024-05-24 02:30
Registration Form
訂正有価証券届出書(新規公開時)
Japanese 1.6 MB
2024-05-08 08:00
Registration Form
有価証券届出書(新規公開時)
Japanese 3.0 MB

Automate Your Workflow. Get a real-time feed of all 株式会社D&Mカンパニー filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for 株式会社D&Mカンパニー

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for 株式会社D&Mカンパニー via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

PeptiDream Inc. Logo
Discovers peptide therapeutics via a proprietary platform and markets radiopharmaceuticals.
Japan
4587
Perion Network Ltd. Logo
AI-powered ad tech delivering omnichannel solutions for advertisers and publishers.
United States of America
PERI
PharmaCyte Biotech, Inc. Logo
Developing encapsulated cell therapies for targeted cancer and diabetes treatments.
United States of America
PMCB
PharmaLundensis AB Logo
Develops treatments for heavy metal toxicity and serious respiratory illnesses.
Sweden
PHAL
Pharos iBio Co., Ltd. Logo
AI-powered drug development for rare and refractory diseases, focusing on oncology.
South Korea
388870
PhoenixBio Co.,Ltd. Logo
CRO providing humanized liver mouse models and testing services for preclinical drug development.
Japan
6190
P&K Skin Research Center Co.,Ltd. Logo
Clinical research for dermatological testing in cosmetics, pharma, and health food sectors.
South Korea
347740
Plantarc Bio Ltd. Logo
Developing high-yield, resilient crops via gene discovery for global seed companies.
Israel
PLNT
Polymetal International plc Logo
A top global gold and silver producer with mining and exploration operations in Kazakhstan.
Kazakhstan
POLY
Poxel Logo
Develops drugs for metabolic diseases, including NASH, rare diseases, and an approved diabetes drug.
France
POXEL

Talk to a Data Expert

Have a question? We'll get back to you promptly.